Galena Biopharma, Inc. (Nasdaq: GALE) was issued a key patent, originally allowed in March 2012, from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE